1. Home
  2. ZURA vs MAXN Comparison

ZURA vs MAXN Comparison

Compare ZURA & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • MAXN
  • Stock Information
  • Founded
  • ZURA 2022
  • MAXN 2019
  • Country
  • ZURA United States
  • MAXN Singapore
  • Employees
  • ZURA N/A
  • MAXN N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • MAXN Semiconductors
  • Sector
  • ZURA Health Care
  • MAXN Technology
  • Exchange
  • ZURA Nasdaq
  • MAXN Nasdaq
  • Market Cap
  • ZURA 69.9M
  • MAXN 56.0M
  • IPO Year
  • ZURA N/A
  • MAXN N/A
  • Fundamental
  • Price
  • ZURA $1.92
  • MAXN $3.99
  • Analyst Decision
  • ZURA Buy
  • MAXN Sell
  • Analyst Count
  • ZURA 10
  • MAXN 1
  • Target Price
  • ZURA $12.67
  • MAXN $4.00
  • AVG Volume (30 Days)
  • ZURA 309.4K
  • MAXN 115.7K
  • Earning Date
  • ZURA 11-06-2025
  • MAXN 08-14-2025
  • Dividend Yield
  • ZURA N/A
  • MAXN N/A
  • EPS Growth
  • ZURA N/A
  • MAXN N/A
  • EPS
  • ZURA N/A
  • MAXN N/A
  • Revenue
  • ZURA N/A
  • MAXN $176,414,000.00
  • Revenue This Year
  • ZURA N/A
  • MAXN $100.37
  • Revenue Next Year
  • ZURA N/A
  • MAXN $24.61
  • P/E Ratio
  • ZURA N/A
  • MAXN N/A
  • Revenue Growth
  • ZURA N/A
  • MAXN N/A
  • 52 Week Low
  • ZURA $0.97
  • MAXN $2.49
  • 52 Week High
  • ZURA $5.07
  • MAXN $14.49
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 53.10
  • MAXN 53.38
  • Support Level
  • ZURA $1.97
  • MAXN $3.75
  • Resistance Level
  • ZURA $2.19
  • MAXN $4.18
  • Average True Range (ATR)
  • ZURA 0.12
  • MAXN 0.24
  • MACD
  • ZURA -0.15
  • MAXN 0.02
  • Stochastic Oscillator
  • ZURA 84.18
  • MAXN 78.36

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.

Share on Social Networks: